Search

  • Sort by

  • Category

  • Post Type

  • Reset

Colorado Mother Works to Raise Awareness About Addiction and Self-Harm

May 8, 2019
Posted in , ,

Grand Junction resident Andrea Thomas lost her daughter Ashley to counterfeit oxycodone in June 2018. Now, she is determined to protect others. Her new foundation, Voices for Awareness, promotes awareness about substance abuse and self-harm. On July 27, 2019, the organization will hold its first conference—free to the public—at Costa Mesa University, as well as the “Fight for Awareness,” a professional boxing event in which fighters from all over Colorado will dedicate their match to a loved one lost to substance abuse or suicide.

Read More

Three Stamford, Connecticut Residents Charged With Trafficking Thousands of Counterfeit Oxycodone Pills, One Has Pleaded Guilty

May 3, 2019
Posted in ,

According to a press release from the U.S. Department of Justice (DOJ), a trio of Connecticut residents has been indicted on charges they were running an organization that specialized in manufacturing counterfeit pills containing fentanyl and selling them via the Internet to purchasers throughout the United States.

Read More

Former FBI Director Warns About the Hidden Risks of Drug Importation

May 1, 2019
Posted in ,

In this editorial published on April 30, 2019, former FBI Director Louis Freeh talks about the safety risks of drug importation: “There are hidden risks and costs associated with the scheme that have not been getting much attention which impact your health and Colorado law enforcement’s ability to keep us safe.”

Read More

ACTION: Speak up for safety in Oregon!

April 30, 2019

What’s happening? The Oregon legislature is working through a number of bills to lower healthcare costs which is important, as healthcare costs are a challenge across Oregon. Of all the proposals being discussed, one of them sacrifices safety to achieve cost savings: foreign drug importation. There are three bills which purport to get medicine from Canada: HB2680, HB2689, and SB…

Read More

New Mexico Pharmacists Association Expresses Concern Over Allowing Drug Importation In Letter to Congress

April 30, 2019
Posted in ,

The New Mexico Pharmacists Association recently sent their own letter to members of Congress expressing their concerns about allowing drug importation. PSM had the chance to speak with their executive director to learn more about the realities and misconceptions that people have about prescription drugs and drug importation…

Read More

New York District Attorney Indicts Major Online Drug Fake Xanax and Illicit Drug Seller

April 30, 2019
Posted in ,

The office of Manhattan District Attorney Cyrus R. Vance Jr. announced the largest counterfeit pill seizure in New Jersey history this month. In addition to large quantities of other illicit drugs, between 420,000 and 620,000 counterfeit Xanax were discovered during the arrest and search of Chester Anderson, Jarrette Codd, and Ronald MacCarty for their alleged role in selling $2.3 million worth of illicit drugs via the internet.

Read More

Economist questions the fundamentals of importation: “It flunks a basic policy analysis.”

April 29, 2019
Posted in ,

In this editorial published on April 26, 2019, Douglas Holtz-Eakin, economist and President of American Action Forum, questions economic truths about drug importation:

“Drug reimportation has long been the fool’s gold of health policy, and the Florida bill is no different. It flunks a basic policy analysis. But most amazing, it is drafted to raise hope, but not actually help Floridians.”

Read More

News Outlet Truth Test Confirms Dangers of Florida’s Importation Legislation in PSM Ad

April 29, 2019
Posted in ,

We recently ran an ad in Florida about the dangers of attempting to import medicine from Canada, and the risk of getting medicine from other countries like China where much of the world’s counterfeits come from. WESH 2 News serving Orlando put the ad through their exclusive Truth Test on April 25, 2019, and the claims in the ad rang true. The…

Read More

Journalist on drug importation: “There is a real risk.”

April 28, 2019
Posted in ,

In this piece published in the Washington Free Beacon on April 25, 2019, staff writer Charles Fain Lehman explores issues around Florida’s drug importation proposal. “Critics,” he notes, “fear that the actual realities of regulatory oversight—especially in the hand of an as-yet-unnamed private vendor—will simply be too challenging to manage responsibly.”

Read More

Utah pharmacist and state senator: Importation raises “serious concerns about drug safety”

April 27, 2019
Posted in ,

In this piece, which was published in The Deseret News on April 24, 2019, pharmacist and Utah State Senate Majority Leader Evan Vickers raises serious concerns about importation as a strategy to lower drug prices:

“Anyone who truly understands how drugs are sold and distributed in the U.S. knows that there are very solid technical reasons that such importation is not viable. There are also serious concerns about drug safety, since the CHS cannot guarantee origin and purity on foreign-sourced drugs.”

Read More